CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-15 | Chappell Todd Chief Operating Officer | Grant or award | +7,500 | 24,464 | ||
| 2026-06-16 | Chappell Todd Chief Operating Officer | Sale | −3,168 | $10.83 | $34K | 16,964 |
| 2026-02-02 | Chappell Todd Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2025-12-15 | Chappell Todd Chief Operating Officer | Grant or award | +20,132 | 20,132 | ||
| 2025-02-03 | Chappell Todd Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +34,500 | 34,500 | ||
| 2023-11-03 | Chappell Todd Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +13,625 | 13,625 | ||
| 2023-11-03 | Chappell Todd Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +4,968 | 4,968 | ||
| 2023-11-03 | Chappell Todd Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +5,128 | 5,128 | ||
| 2023-11-03 | Chappell Todd Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +62,651 | 62,651 |
Page 1 of 1 · 9 trades